about
Genetic variants within the MHC region are associated with immune responsiveness to childhood vaccinationsSearching for the human genetic factors standing in the way of universally effective vaccinesCurrent hepatitis B virus infection situation in Indonesia and its genetic diversityNew genetic associations detected in a host response study to hepatitis B vaccineHBV vaccination status and response to hepatitis B vaccine among Iranian dentists, correlation with risk factors and preventive measuresHost genetic factors and vaccine-induced immunity to hepatitis B virus infection.Host genetic factors and vaccine-induced immunity to HBV infection: haplotype analysisGenetic determinants of immune-response to a polysaccharide vaccine for typhoid.A genome-wide association study of hepatitis B vaccine response in an Indonesian population reveals multiple independent risk variants in the HLA region.Protective effect of hepatitis B vaccine combined with two-dose hepatitis B immunoglobulin on infants born to HBsAg-positive mothers.Vaccination with M2e-based multiple antigenic peptides: characterization of the B cell response and protection efficacy in inbred and outbred mice.CD3Z genetic polymorphism in immune response to hepatitis B vaccination in two independent Chinese populationsStrategies to eliminate HBV infection.Partial delipidation improves the T-cell antigenicity of hepatitis B virus surface antigen.Observational study of vaccine efficacy 24 years after the start of hepatitis B vaccination in two Gambian villages: no need for a booster doseIdentification of the immunogenic domains in HBsAg preS1 region using overlapping preS1 fragment fusion proteinsPrevalence of National Responsiveness to HBV Vaccine After 22 Years of Iranian Expanded Program on Immunization (EPI): A Systematic Review and Meta-Analysis StudyHepatitis B virus splice-generated protein induces T-cell responses in HLA-transgenic mice and hepatitis B virus-infected patientsGenomic correlates of variability in immune response to an oral cholera vaccine.Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century.Recent developments with B-cell epitope identification for predictive studies.New developments and concepts related to biomarker application to vaccines.Atypical serological profiles in hepatitis B virus infection.Hepatitis B vaccination in chronic kidney disease patients: a call for novel vaccines.Old and new adjuvants for hepatitis B vaccines.Non-responsiveness to hepatitis B surface antigen vaccines is not caused by defective antigen presentation or a lack of B7 co-stimulation.Unimpaired immunogenicity of yeast-expressed hepatitis B surface antigen stored at elevated temperatures.Immune memory response induced in vitro by recombinant hepatitis B surface antigen challenge 13-18 years after primary vaccination.Different effect of HBV vaccine after liver transplantation between chronic HBV carriers and non-HBV patients who received HBcAb-positive grafts.Hepatitis B virus surface protein mutations clustered mainly in CTL immune epitopes in chronic carriers: results of an Iranian nationwide study.Hepatitis B virus surface antigen impairs myeloid dendritic cell function: a possible immune escape mechanism of hepatitis B virus.
P2860
Q23910391-B542F192-6502-4754-9E38-23DE8D0BEE01Q27007034-29F169A6-80C2-4389-AB3F-56D77B1F2D60Q28074068-56FD745C-9FCF-4B5C-9122-1DC09FEA2C7EQ28276283-6E31B4DC-B137-4F19-AEA5-3B64EAA7EB9CQ28388849-553B5C01-7CF6-4648-8896-F7BB0D80422BQ33325499-A3F362CB-FD1C-4332-A99B-F0E1C0BF80D1Q33678959-F8B9C390-54F5-4508-93D4-2959215A6B2DQ33901610-6D5AD52B-B3A6-44EB-B898-92EC63588EDBQ33963300-1FCDB20C-B4C8-4715-84CD-CFA23C00A6CAQ34067032-2E95FD4A-91F9-4279-A865-055C2CD415C6Q34105207-4E0AD791-7004-42EE-B333-2AAFA80B0D27Q34247198-9E0F9DC5-43FE-4FEE-AF8E-FF4E42782BC8Q34308129-81857791-3BD4-4813-87C8-226524FB083CQ34545711-4B5E8EEA-A689-43F9-BFFF-EA3F59FD7B63Q34637622-1C38D0E0-EA95-42F0-BB31-77BB703F3D9DQ35010703-9D251599-052E-4A66-93D2-D20D01CC346FQ35671639-597B2CCD-D9CE-4B6D-AD34-535B0DD30ADCQ35857548-E6BE38F9-2396-4137-984C-AE0DB7DCF9C0Q37102102-DC9CE1E4-0477-44DF-971B-8FB92C469718Q37119456-38809701-ABBF-4566-9F43-EFCF54007E37Q37311033-2D3C8655-EA07-45C2-9239-CDC37F511499Q37927213-D5DA20C5-0E04-4169-A677-8BCC54155476Q38063427-47DCD9D4-414E-4F87-BE1C-F2A5F721478AQ38242238-34E00CD1-93B5-4E8C-914B-6161211DC467Q38293586-83B5461D-C8F6-4E33-8D4B-897F073925F7Q40447718-D5F26705-0CDE-442B-8226-16879422B452Q40458714-80059DBD-7954-4142-9D01-76426CE95BFBQ42205054-D8416B83-5443-4A95-8C4B-42D28A4B3D25Q43640407-EEC06BE7-0C96-43C6-A814-9760FE293C61Q43777564-56C66F84-873C-47D5-83C6-B82902A88C9EQ45393651-DE3AE86A-E7B4-4E82-921C-78BB9E90AE27
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Immunogenetics of the response to HBsAg vaccination.
@ast
Immunogenetics of the response to HBsAg vaccination.
@en
type
label
Immunogenetics of the response to HBsAg vaccination.
@ast
Immunogenetics of the response to HBsAg vaccination.
@en
prefLabel
Immunogenetics of the response to HBsAg vaccination.
@ast
Immunogenetics of the response to HBsAg vaccination.
@en
P1433
P1476
Immunogenetics of the response to HBsAg vaccination.
@en
P2093
David R Milich
Geert G Leroux-Roels
P304
P356
10.1016/S1568-9972(03)00031-4
P577
2003-09-01T00:00:00Z